Efe Eworuke (E Eworuke)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Electronic Health Record

Juvenile Idiopathic Arthritis

Top Venues

Pharmacoepidemiology and drug safety

Regional anesthesia and pain medicine

American journal of epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Casie E Horgan, Jillian Burk, Efe Eworuke, Danijela Stojanovic, Jennifer G Lyons, Èrick Moyneur, Ann McMahon, Judith C Maro
Identifying Pediatric Hypertension in Observational Data: Comparing Clinical and Claims Cohorts in Real World Data. American journal of epidemiology (2024)
Efe Eworuke, Mayura U Shinde, Laura Hou, J Michael Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Jesper Hallas, Daniel Scarnecchia, Yuanling Liang, Deborah Johnson, Robert W Platt, Hana Lee, Marie C Bradley
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark. Pharmacoepidemiology and drug safety 33 (9) (2024)
Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. BMJ open 13 (4) (2023)
Adebola Ajao, Austin Cosgrove, Efe Eworuke, Mohamed Mohamoud, Rongmei Zhang, Oren Shapira, Joy Kolonoski, John G Connolly
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants. Pharmacoepidemiology and drug safety 31 (11) (2022)
Melissa Khashei, Scott Janiczak, Christopher St Clair, Wei Liu, Jae Joon Song, Wei Hua, Monique Falconer, Efe Eworuke
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient-reported COVID-19 experiences. Pharmacoepidemiology and drug safety (2022)
Efe Eworuke, Nicole Haug, Marie C Bradley, Austin Cosgrove, Tancy Zhang, Elizabeth C Dee, Sruthi Adimadhyam, Andrew Petrone, Hana Lee, Tiffany Woodworth, Sengwee Toh
Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States. JNCI cancer spectrum 5 (2) (2021)
Efe Eworuke, Talia J Menzin, Emily C Welch, Joy Kolonoski, Ting-Ying Huang
Utilization of Sacubitril/Valsartan in Real-World Settings. American journal of cardiovascular drugs : drugs, devices, and other interventions 20 (6) (2021)
Efe Eworuke, Judith Racoosin, David J Graham
Response to the letter to the editor. Regional anesthesia and pain medicine (2021)
Efe Eworuke, Laura Hou, Rongmei Zhang, Hui-Lee Wong, Peter Waldron, Abby Anderson, Audrey Gassman, David Moeny, Ting-Ying Huang
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin. Drug safety 44 (7) (2021)
Efe Eworuke, Emily C Welch, Anne Tobenkin, Judith C Maro
Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure. Drug safety 42 (7) (2020)
Mohamed Mohamoud, Casie Horgan, Efe Eworuke, Elizabeth Dee, Justin Bohn, Oren Shapira, Monica A Muñoz, Danijela Stojanovic, Veronica Sansing-Foster, Adebola Ajao, Lois La Grenade
Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis. Pharmacotherapy 40 (11) (2020)
Efe Eworuke, Leah Crisafi, Jiemin Liao, Sandia Akhtar, Martha Van Clief, Judith A Racoosin, Michael Wernecke, Thomas E MaCurdy, Jeffrey A Kelman, David J Graham
Risk of serious spinal adverse events associated with epidural corticosteroid injections in the Medicare population. Regional anesthesia and pain medicine 46 (3) (2020)
Judith C Maro, Efe Eworuke, Laura Hou, Emily C Welch, Margie R Goulding, Rima Izem, Joo-Yeon Lee, Sengwee Toh, Bruce H Fireman, Michael D Nguyen
Conducting prospective sequential surveillance in real-world dynamic distributed databases. Pharmacoepidemiology and drug safety 29 (10) (2020)
Sarah K Dutcher, Efe Eworuke, Michael D Blum, Robert Ball
Using real-world data to evaluate biosimilar switching. Pharmacoepidemiology and drug safety 29 (7) (2019)
Sarah K Dutcher, Elnara Fazio-Eynullayeva, Efe Eworuke, Amanda Carruth, Elizabeth C Dee, Michael D Blum, Michael D Nguyen, Sengwee Toh, Catherine A Panozzo, Jennifer G Lyons
Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness. Pharmacoepidemiology and drug safety 29 (7) (2019)
Lisa J Herrinton, Tiffany S Woodworth, Efe Eworuke, Laura B Amsden, Liyan Liu, Jo Wyeth, Andrew Petrone, Talia J Menzin, James Williams, Robert Goldfien, Michael Nguyen
Development of an algorithm to detect methotrexate wrong frequency error using computerized health care data. Pharmacoepidemiology and drug safety 28 (10) (2019)
Efe Eworuke, Genna Panucci, Margie Goulding, Rosemarie Neuner, Sengwee Toh
Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants. Pharmacoepidemiology and drug safety 28 (3) (2018)
Efe Eworuke, V Popat, D G Moeny
Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning. Journal of clinical pharmacy and therapeutics 42 (4) (2017)
Efe Eworuke, Joo-Yeon Lee, Lisa Soule, Vaishali Popat, David G Moeny
The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate. Pharmacoepidemiology and drug safety 26 (7) (2017)